Nadim Ahmed, President and CEO at Cullinan Oncology, Inc. (CGEM), sold 707 shares at $9.15 ($6K) on 2023-05-23, disclosed to the SEC on 2023-05-24.
Open-market sale of $6k CGEM by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| CGEM | SELL | 2025-12-29 | $199K | — | Filing → |
| CGEM | SELL | 2025-02-27 | $214K | — | Filing → |
| CGEM | SELL | 2024-12-27 | $100K | — | Filing → |